Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTRA-CELLULAR THERAPIES, INC.

(ITCI)
  Report
Real-time Estimate Cboe BZX  -  10:44 2022-11-28 am EST
52.92 USD   +1.31%
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperform Rating
MT
11/03Intra-Cellular Therapies Reports Narrower Q3 Loss, Higher Revenue; Shares Jump
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
CommuniquÚs de presse de la sociÚtÚ INTRA-CELLULAR THERAPIES, INC.
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/03Intra-cellular : Q3 Earnings Snapshot
AQ
11/03INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
11/03Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
11/03Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corp..
AQ
10/27Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call a..
AQ
08/09Intra Cellular Therapies : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES CORP..
PU
08/09INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
08/09Intra-cellular : Q2 Earnings Snapshot
AQ
08/09Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
08/09Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Cor..
AQ
08/02Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call ..
AQ
06/13Intra-cellular Therapies, Inc. : Submission of Matters to a Vote of Security Holders (form..
AQ
06/13Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations ..
AQ
05/10INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
05/10Intra-cellular : Q1 Earnings Snapshot
AQ
05/10Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
05/10Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corp..
AQ
05/03Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call a..
AQ
04/26Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA (lu..
AQ
04/25Intra Cellular Therapies : Announces FDA Approval of New Dosage Strengths for CAPLYTA« (lu..
PU
04/25Intra-cellular Therapies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
04/25Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA« (l..
AQ
04/21Intra Cellular Therapies : Announces Appointment of E. Rene Salas to Board of Directors - ..
PU
04/21Intra-cellular Therapies, Inc. : Change in Directors or Principal Officers, Financial Stat..
AQ
04/21Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors
AQ
04/05Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Confe..
AQ
03/01Intra Cellular Therapies : REPORTS FOURTH QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS AND..
PU
03/01Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
03/01Intra-cellular : Q4 Earnings Snapshot
AQ
03/01INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
03/01Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results an..
AQ
02/22Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Co..
AQ
02/10Intra-Cellular Therapies to Present at the 11th Annual SVB Leerink Global Healthcare Co..
AQ
01/10Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Fu..
AQ
01/07Intra Cellular Therapies : Announces Closing of $460 Million Public Offering Including Ful..
PU
01/07Intra-cellular Therapies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
01/07Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Fu..
AQ
01/05Intra Cellular Therapies : Information relating to Item 14 of the Registration Statement o..
PU
01/05Intra Cellular Therapies : Financial Statements - Form 8-K
PU
01/05Intra-cellular Therapies, Inc. : Entry into a Material Definitive Agreement, Other Events,..
AQ
01/05Intra-cellular Therapies, Inc. : Financial Statements and Exhibits (form 8-K)
AQ
01/04Intra-Cellular Therapies Prices Public Offering of Common Stock
GL
01/04Intra Cellular Therapies : Announces Proposed Public Offering of Common Stock - Form 8-K
PU
01/04Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
01/03Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
GL
01/03Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
GL
01/03Intra-Cellular Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conferenc..
AQ
2021Intra-cellular Therapies, Inc. : Entry into a Material Definitive Agreement, Financial Sta..
AQ
2021Intra Cellular Therapies : Announces U.S. FDA Approval of CAPLYTA« (lumateperone) for the ..
PU
2021Intra-cellular Therapies, Inc. : Other Events, Financial Statements and Exhibits (form 8-K..
AQ
2021Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA« (lumateperone) for the..
GL
2021Intra-Cellular Therapies Announces U.S. FDA Approval of CAPLYTA« (lumateperone) for the..
GL
2021Intra-cellular Therapies, Inc. : Other Events, Notice of Delisting or Failure to Satisfy a..
AQ
2021Intra-Cellular Therapies Mourns the Passing of Director, Dr. Richard Lerner
AQ
2021INTRA-CELLULAR THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
2021INTRA-CELLULAR THERAPIES REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND PROVIDES CORP..
PU
2021Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
2021Intra-cellular : Q3 Earnings Snapshot
AQ
2021Intra-Cellular Therapies Reports Third Quarter 2021 Financial Results and Provides Corp..
GL
2021Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call a..
AQ
2021Intra Cellular Therapies : Announces Amended Start Time to Virtual Event on Wednesday, Oct..
AQ
2021Intra Cellular Therapies : to Host a Virtual Event to Feature Highlights of Several of its..
AQ
2021Intra Cellular Therapies : Cellular Therapies to Host a Virtual Event to Feature Highlight..
GL
2021Intra Cellular Therapies : Announces Publication of Lumateperone Pivotal Phase 3 Study in ..
AQ
2021Intra Cellular Therapies : to Present at the 2021 Cantor Virtual Global Healthcare Confere..
AQ
2021Intra-Cellular Therapies Announces Publications Highlighting Beneficial Effects of Phos..
GL
2021Intra Cellular Therapies : to Present at the Canaccord Genuity 41st Annual Growth Conferen..
AQ
2021Intra-cellular : Q2 Earnings Snapshot
AQ
2021Intra-cellular Therapies, Inc. : Results of Operations and Financial Condition, Other Even..
AQ
2021Intra Cellular Therapies : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
2021Intra Cellular Therapies : Reports Second Quarter 2021 Financial Results and Provides Corp..
AQ
2021Intra Cellular Therapies : to Host Second Quarter 2021 Financial Results Conference Call a..
AQ
2021Intra Cellular Therapies : Certificate of Amendment to the Restated Certificate of Incorpo..
PU
2021Intra-cellular Therapies, Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fisca..
AQ
1  2  3  4  5Next
Upcoming event on INTRA-CELLULAR THERAPIES, INC.